A significant discovery in cancer study is emerging with the use of VHH fragments to re-engage damaged p53. This crucial cancer inhibitor protein is frequently disabled in various types of malignancies, resulting https://bookmarkspy.com/story23584596/vhh-fragments-reactivate-p53-new-potential-pathway-for-tumor-management